Browsing Health Sciences by Subject "Chalcones"
Now showing items 1-3 of 3
-
Monoamine oxidase inhibitory activities of heterocyclic chalcones
(2013)Parkinson’s disease is the second most common age-related neurodegenerative disease after Alzheimer’s disease. The characteristic pathological feature of Parkinson’s disease is the loss of neurons in the substantia nigra ... -
Syntheses of chalcones and 2–aminopyrimidines and their evaluation as monoamine oxidase inhibitors and as adenosine receptor antagonists
(North-West University, 2013)Background and rationale - Parkinson’s disease is a neurodegenerative disorder characterised by reduced levels of dopamine in the brain. The cause of Parkinson's disease is still unknown; however several theories pertaining ... -
Synthesis and evaluation of cyclic chalcones as monoamine oxidase inhibitors
(North-West University (South Africa) , Potchefstroom Campus, 2016)Parkinson’s disease (PD) is the second most-prevalent age-related neurodegenerative disorder following Alzheimer’s disease. The manifestation of clinical PD begins after a loss of neurons from the substantia nigra pars ...
